Compare REXR & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REXR | CRL |
|---|---|---|
| Founded | 2013 | 1947 |
| Country | United States | United States |
| Employees | N/A | 20100 |
| Industry | Real Estate Investment Trusts | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 8.3B |
| IPO Year | N/A | 1999 |
| Metric | REXR | CRL |
|---|---|---|
| Price | $37.66 | $168.92 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 12 |
| Target Price | $42.10 | ★ $199.64 |
| AVG Volume (30 Days) | ★ 2.6M | 1.1M |
| Earning Date | 01-01-0001 | 05-19-2026 |
| Dividend Yield | ★ 4.69% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,857,601,000.00 |
| Revenue This Year | $1.58 | $2.51 |
| Revenue Next Year | $3.73 | $4.66 |
| P/E Ratio | $43.28 | ★ N/A |
| Revenue Growth | N/A | ★ 10.48 |
| 52 Week Low | $29.68 | $91.86 |
| 52 Week High | $44.38 | $228.88 |
| Indicator | REXR | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 35.32 | 32.93 |
| Support Level | $36.32 | $146.33 |
| Resistance Level | $37.79 | $164.36 |
| Average True Range (ATR) | 0.91 | 10.68 |
| MACD | -0.21 | -3.27 |
| Stochastic Oscillator | 10.80 | 27.56 |
Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.